Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126023782 | 12602378 | 2 | F | 201606 | 20160727 | 20160728 | 20160810 | PER | US-PFIZER INC-2016362793 | PFIZER | 72.00 | YR | F | Y | 93.00000 | KG | 20160810 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126023782 | 12602378 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | Oral | AT A LOW DOSE | 20882 | FILM-COATED TABLET | |||||||||
| 126023782 | 12602378 | 2 | SS | NEURONTIN | GABAPENTIN | 1 | Oral | 600MG TABLETS, 2 IN THE MORNING, 1 IN THE AFTERNOON, AND 1 AT BEDTIME | 20882 | FILM-COATED TABLET | TID | ||||||||
| 126023782 | 12602378 | 3 | C | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | 2 DF, 3X/DAY | 0 | 2 | DF | TABLET | TID | |||||||
| 126023782 | 12602378 | 4 | C | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | 200MG, TAKES 2 TABS IN THE MORNING, 1.5 IN THE AFTERNOON, AND 2 AT BEDTIME | 0 | TABLET | TID | |||||||||
| 126023782 | 12602378 | 5 | C | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | [HYDROCODONE BITARTRATE 7.5 MG]/[ACETAMINOPHEN 325 MG] ONLY 1 ABOUT TWICE A MONTH | 0 | TABLET | |||||||||
| 126023782 | 12602378 | 6 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 1000 MG, DAILY | 0 | 1000 | MG | TABLET | ||||||||
| 126023782 | 12602378 | 7 | C | FOLIC ACID. | FOLIC ACID | 1 | 800 MG, DAILY | 0 | 800 | MG | TABLET | ||||||||
| 126023782 | 12602378 | 8 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, DAILY | 0 | 81 | MG | TABLET | ||||||||
| 126023782 | 12602378 | 9 | C | DOCUSATE | DOCUSATE | 1 | Oral | 100MG, 1 CAPSULE BY MOUTH TWICE PER DAY | 0 | 100 | MG | CAPSULE | BID | ||||||
| 126023782 | 12602378 | 10 | C | INDERAL LA | PROPRANOLOL HYDROCHLORIDE | 1 | 160MG CAPSULE, 1 AT BEDTIME | 0 | 160 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126023782 | 12602378 | 1 | Trigeminal neuralgia |
| 126023782 | 12602378 | 3 | Trigeminal neuralgia |
| 126023782 | 12602378 | 4 | Seizure |
| 126023782 | 12602378 | 5 | Pain |
| 126023782 | 12602378 | 6 | Supplementation therapy |
| 126023782 | 12602378 | 7 | Supplementation therapy |
| 126023782 | 12602378 | 8 | Blood disorder |
| 126023782 | 12602378 | 9 | Constipation |
| 126023782 | 12602378 | 10 | Migraine |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126023782 | 12602378 | Abdominal pain upper | |
| 126023782 | 12602378 | Accident | |
| 126023782 | 12602378 | Dyskinesia | |
| 126023782 | 12602378 | Fatigue | |
| 126023782 | 12602378 | Muscle disorder | |
| 126023782 | 12602378 | Muscle spasms | |
| 126023782 | 12602378 | Pain | |
| 126023782 | 12602378 | Product use issue | |
| 126023782 | 12602378 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126023782 | 12602378 | 1 | 20160621 | 0 | ||
| 126023782 | 12602378 | 5 | 1996 | 0 | ||
| 126023782 | 12602378 | 6 | 1998 | 0 | ||
| 126023782 | 12602378 | 7 | 1998 | 0 | ||
| 126023782 | 12602378 | 8 | 2006 | 0 | ||
| 126023782 | 12602378 | 9 | 2014 | 0 | ||
| 126023782 | 12602378 | 10 | 1997 | 0 |